converting between glp-1 agonists GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 Agonists for Weight Loss:

There were 78 subjects randomized to receive the diabetes drug Lixisenatide and 78 randomized to a placebo

Despite the promising potential of GLP-1 RAs, it is essential to conduct further clinical studies to confirm their long-term efficacy and safety in patients with HFpEF

Emerging evidence indicates their potential role in the management of diverse obesity-related comorbidities, including metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, polycystic ovary syndrome, neurodegenerative disorders, and even substance use disorders

What does this all mean

Measurements were performed using a Hologic Discovery Wi DXA scanner and analyzed using APEX software version 13.4

CPAP remains the most effective therapy for symptom control, but long-term adherence is poor, with 3050% of patients unable to maintain regular use (11, 12)